Deceptive Trade Practice

Coronavirus Employee Protections Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating employers across the United States for failure to provide adequate health and safety protections to employees amidst the COVID-19 pandemic, resulting in widespread infection. Essential service workers must travel to, and engage in productive activity at, their typical place of employment, despite the bevy of risk factors involved. […]

Product Defect

Metformin Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating manufacturers of the widely used diabetes drug metformin, known by the common brand names Glucofage, Riomet, and Glumetza, for product contamination. Online pharmacy Valisure tested various metformin batches for impurities containing N-nitrosodimethylamine, or NDMA, a probable human carcinogen, and found sixteen contaminated batches. One batch contained sixteen times […]

Product Defect

Ranitidine Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating manufacturers of the prescription and over-the-counter heartburn medication ranitidine, known by the brand name Zantac. The U.S. Food and Drug Administration (FDA) recently requested manufacturers pull the drug from the market, citing an ongoing investigation that found many ranitidine samples contained hazardous levels of the contaminant NDMA, a […]